21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.22.Z - Head office activities and management consultancy
73.11.Z - Advertising agency activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
78.30.Z - Employment activities
82.11.Z - Office administrative support activities and other business support services
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 105,7 | 132,6 | 191 | 44,1 |
Gross profit (loss) | 33,7 | 34,8 | 67,7 | 94,6 |
Net profit (loss) | 32,7 | 32,3 | 66,3 | 105,3 |
Cash | 102,7 | 132,5 | 190,9 | 44,1 |
Liabilities and provisions for liabilities | 13,7 | 8,3 | 0,4 | -94,9 |
Short time liabilities | 13,7 | 8,3 | 0,4 | -94,9 |
Working assets | 105,6 | 132,5 | 190,9 | 44,1 |
Equity capital | 92 | 124,3 | 190,6 | 53,4 |
Operating profit (EBIT) | -21,7 | -2,2 | -2,4 | -5,6 |
% | % | % | p.p. | |
Profitability of capital | 35,5 | 26 | 34,8 | 8,8 |
Equity capital to total assets | 87 | 93,7 | 99,8 | 6,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane